ICU Medical, Inc.

Historical 13F Holders

Symbol
ICUI
CUSIP
44930G107
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 44930G107 since 12/18/2024, newest first.

Filer % of Class Filed
Fuller & Thaler Asset Management, Inc. 13G/A Amendment 3 5.2% 8/14/2026
Event 6/30/2026
Janus Henderson Group Ltd. 13G/A Amendment 12 11.1% 8/13/2026
Event 6/30/2026
Fuller & Thaler Asset Management, Inc. 13G/A Amendment 2 4.9% 5/13/2026
Event 3/31/2026
Vanguard Capital Management LLC 13G 5.2% 4/30/2026
Event 3/31/2026
Vanguard Portfolio Management LLC 13G 5.8% 4/29/2026
Event 3/31/2026
Vanguard Group Inc 13G/A Amendment 1 0% 3/27/2026
Event 3/13/2026
Janus Henderson Group PLC 13G/A Amendment 11
10.0% 8/14/2025
Event 6/30/2025
Janus Henderson Group PLC 13G/A Amendment 10
10.0% 5/7/2025
Event 4/30/2025
Janus Henderson Group PLC 13G/A Amendment 9
9.9% 2/14/2025
Event 12/31/2024

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 10 331 k $53.2 M
2026 Q2 296 30.0 M $3.85 B
2026 Q1 286 25.0 M $3.23 B
2025 Q4 301 27.0 M $3.84 B
2025 Q3 277 26.5 M $3.17 B
2025 Q2 283 25.1 M $3.32 B
2025 Q1 297 24.5 M $3.41 B
2024 Q4 300 24.2 M $3.76 B
2024 Q3 302 25.3 M $4.59 B
2024 Q2 267 25.1 M $2.98 B
2024 Q1 261 24.8 M $2.66 B
2023 Q4 256 23.0 M $2.29 B
2023 Q3 230 22.3 M $2.66 B
2023 Q2 239 22.2 M $3.96 B
2023 Q1 242 22.7 M $3.74 B
2022 Q4 262 22.9 M $3.61 B
2022 Q3 253 25.1 M $3.79 B
2022 Q2 262 21.6 M $3.56 B
2022 Q1 307 20.9 M $4.66 B
2021 Q4 309 20.2 M $4.80 B
2021 Q3 295 20.1 M $4.70 B
2021 Q2 284 20.3 M $4.18 B
2021 Q1 300 20.1 M $4.13 B
2020 Q4 298 20.2 M $4.34 B
2020 Q3 294 19.4 M $3.54 B
2020 Q2 307 19.5 M $3.60 B
2020 Q1 286 20.0 M $4.02 B
2019 Q4 279 20.0 M $3.74 B
2019 Q3 273 19.2 M $3.06 B
2019 Q2 288 19.7 M $4.95 B
2019 Q1 306 18.9 M $4.52 B
2018 Q4 301 19.3 M $4.43 B
2018 Q3 375 16.5 M $4.67 B
2018 Q2 358 15.3 M $4.47 B
2018 Q1 300 15.0 M $3.78 B
2017 Q4 269 15.6 M $3.36 B
2017 Q3 230 15.9 M $2.95 B
2017 Q2 235 15.7 M $2.71 B
2017 Q1 238 15.6 M $2.38 B
2016 Q4 257 15.3 M $2.26 B
2016 Q3 237 14.5 M $1.83 B
2016 Q2 225 14.5 M $1.62 B
2016 Q1 226 14.4 M $1.50 B
2015 Q4 234 14.2 M $1.60 B
2015 Q3 214 14.7 M $1.61 B
2015 Q2 198 14.7 M $1.41 B
2015 Q1 190 14.5 M $1.35 B
2014 Q4 201 14.3 M $1.18 B
2014 Q3 179 14.6 M $940 M
2014 Q2 169 14.8 M $898 M
2014 Q1 169 14.3 M $855 M